Divi's Laboratories Ltd (NSE:DIVISLAB) Share Price

Company Profile

Business description
Divi's Laboratories Ltd is a specialty and generic drug manufacturing company. It is engaged in the manufacture of Active Pharmaceutical ingredients (API), Intermediates, and Nutraceutical ingredients, with a predominance in exports. It also, through its custom synthesis, supports pharma companies for their patented products business from gram-scale requirements for clinical trials to launch, as well as late-life cycle management. Geographically, the company derives maximum revenue from Europe, and the rest from America, India, Asia (excluding India), and the Rest of the world.
Contact
Cyber Hills
Divi Towers, 1-72/23(P)/DIVIS/303
Gachibowli
HyderabadTG500032
IND
T: +91 4066966300
https://www.divislabs.com
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 March 2027
Employees
9,109

Recommended

Wide moat Eli Lilly receives FDA approval for obesity pill.

Karen Andersen, CFA | 02 April 2026

These companies are our favourite choices for investors wanting to boost Aussie equity exposure.

Simonelle Mody | 02 April 2026

OpenAI, Anthropic, and Databricks are expected to go public this year at massive valuations.

Harrison Rolfes | 02 April 2026

Index	Last price	Change	% Change
All Ordinaries	8,774.90	124.80	-1.40%
CAC 40	7,981.27	164.33	2.10%
DAX 40	23,298.89	618.85	2.73%
Dow JONES (US)	46,565.74	224.23	0.48%
FTSE 100	10,364.79	188.34	1.85%
HKSE	24,960.25	333.78	-1.32%
NASDAQ	21,840.95	250.32	1.16%
Nikkei 225	52,444.58	1,295.10	-2.41%
NZX 50 Index	12,902.15	76.28	0.59%
S&P 500	6,575.32	46.80	0.72%
S&P/ASX 200	8,579.50	105.50	-1.21%
SSE Composite Index	3,915.01	33.54	-0.85%